- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07624266
Comparison of First and Second Capillary Blood Drops for Blood Glucose Measurement
May 31, 2026 updated by: Ayten Kaya, Ordu University
Comparison of Capillary Blood Sampling Techniques for Blood Glucose Measurement in People With Diabetes: An Experimental Study
This study aimed to evaluate the effects of different capillary blood sampling techniques on blood glucose measurement results in people with diabetes.
Blood glucose measurements obtained from the first and second capillary blood drops after antiseptic application were compared.
In addition, measurements obtained with and without finger squeezing were evaluated.
The findings may contribute to improving standardization in capillary blood glucose monitoring procedures and reducing unnecessary repeated finger punctures in clinical practice.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This methodological and experimental study evaluated whether different capillary blood sampling techniques influence blood glucose measurement results in people with diabetes.
The study compared glucose measurements obtained from the first and second capillary blood drops and also evaluated measurements performed with and without finger squeezing under standardized clinical conditions.
The findings are expected to contribute to the standardization of capillary blood glucose monitoring procedures and improve clinical practice by reducing unnecessary repeated finger punctures and enhancing participant comfort.
Study Type
Observational
Enrollment (Actual)
64
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ordu
-
Altinordu, Ordu, Turkey (Türkiye), 52200
- Ordu Univercıty
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adults with diabetes who were hospitalized in the internal medicine clinics of a state hospital during the study period and met the study inclusion criteria.
Description
Inclusion Criteria:
- Aged 18 years or older
- Diagnosed with diabetes mellitus
- Provided written and verbal informed consent to participate in the study
- Eligible for blood glucose measurement after at least 6 hours of fasting
- No condition preventing capillary blood sampling from the fingertip
- Physically and mentally able to undergo the measurement procedures specified in the study
Exclusion Criteria:
- Presence of a physical disability or deformity affecting fingertip blood glucose measurement
- Presence of coagulation disorders (e.g., hemophilia) or severe medical conditions affecting blood sampling
- Use of steroids within the previous 24 hours that could affect blood glucose levels
- Presence of physical or mental conditions limiting compliance with study procedures
- Inability or unwillingness to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between blood glucose measurements obtained with and without finger squeezing
Time Frame: Day 1
|
Comparison of blood glucose values obtained from capillary blood samples collected with and without finger squeezing.
Blood glucose measurements were obtained consecutively during a single study visit (Day 1), first from a capillary blood sample collected without finger squeezing and subsequently from a capillary blood sample collected with finger squeezing during the same blood sampling and measurement session
|
Day 1
|
|
Difference between blood glucose values obtained from the first and second capillary blood drops following antiseptic application
Time Frame: Day 1
|
Comparison of blood glucose values obtained from the first and second capillary blood drops after antiseptic application.
The first and second blood drop measurements were obtained consecutively during the same capillary blood sampling and measurement session.
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2025
Primary Completion (Actual)
July 30, 2025
Study Completion (Actual)
December 30, 2025
Study Registration Dates
First Submitted
May 19, 2026
First Submitted That Met QC Criteria
May 31, 2026
First Posted (Actual)
June 3, 2026
Study Record Updates
Last Update Posted (Actual)
June 3, 2026
Last Update Submitted That Met QC Criteria
May 31, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024/212-BAEK239
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be publicly available due to confidentiality and privacy considerations.
However, statistical data may be provided by the corresponding author upon reasonable request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Capillary Blood Sampling Techniques
-
Medical University of GrazJoanneum Research Forschungsgesellschaft mbHCompleted
-
Centre Hospitalier Universitaire de NiceRecruiting
-
CardioRenalCompletedPotassium MeasurementBelgium
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
University Hospital, AngersCompletedPeripheral Artery DiseaseFrance
-
Assistance Publique - Hôpitaux de ParisUnknown
-
University Hospital, AngersCompletedPeripheral Artery Disease | Claudication, IntermittentFrance
-
University Hospital, MontpellierCompleted
-
Jules DesmeulesCompleted
-
Beijing Friendship HospitalCompletedLung Cancer | Tuberculosis | SarcoidosisChina